Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review

CDH1, as a tumor suppressor gene, contributes sporadic breast cancer (BC) progression. However, the association between CDH1 hypermethylation and BC, and its clinicopathological significance remains unclear. We conducted a meta-analysis to investigate the relationship between the CDH1 methylation pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ruixue, Ding, Ping, Yang, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583122/
https://www.ncbi.nlm.nih.gov/pubmed/26425077
http://dx.doi.org/10.2147/DDDT.S86929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583122/
https://www.ncbi.nlm.nih.gov/pubmed/26425077
http://dx.doi.org/10.2147/DDDT.S86929

Ejemplares similares